Mounjaro Dosing: Weekly Schedule, Titration Steps, and What to Do If You Miss a Dose

Key Takeaways

• Mounjaro is dosed once weekly by subcutaneous injection on the same day each week, with or without food.
• The standard titration starts at 2.5 mg for four weeks, then 5 mg, with optional 2.5 mg increases every four weeks if needed, up to a maximum of 15 mg.
• Doses can shift by up to three days when needed.
• Mounjaro is dosed once every seven days, on the same day each week.
• It can be taken with or without food, at any time of day.

Direct answer (40-60 words)

Mounjaro is dosed once weekly by subcutaneous injection on the same day each week, with or without food. The standard titration starts at 2.5 mg for four weeks, then 5 mg, with optional 2.5 mg increases every four weeks if needed, up to a maximum of 15 mg. Doses can shift by up to three days when needed.

Table of contents

1. The weekly Mounjaro dosing schedule
2. The four-week titration ladder
3. How to choose your injection day
4. What happens if you miss a Mounjaro dose
5. Switching from another GLP-1 to Mounjaro
6. Injection sites and rotation
7. Adjusting the dose for side effects
8. Mounjaro dosing for type 2 diabetes vs. Zepbound for weight loss
9. Compounded tirzepatide dosing differences
10. When to call your provider
11. FAQ
12. Author note and disclaimers

The weekly Mounjaro dosing schedule

Mounjaro is dosed once every seven days, on the same day each week. It can be taken with or without food, at any time of day. The injection takes about 30 seconds.

A typical week looks like:

• Pick an anchor day (Sunday, Monday, whatever fits your life).
• Inject within a window around that day. The pen doesn't care if it's morning or evening.
• Track the date on a calendar or in the Mounjaro app.
• Repeat next week, same day.

Tirzepatide's half-life is about 5 days, so weekly dosing keeps plasma levels relatively stable between injections. Steady-state takes roughly four to five weeks at any given dose.

If you need to change your weekly day for travel, work, or any reason, the prescribing information allows shifting up to 3 days earlier or later as long as the next injection then resumes the new schedule (with at least 3 days between injections).

The four-week titration ladder

Mounjaro dosing isn't a single number. It's a ladder. Most patients climb it over five to six months.

Each step requires a minimum of four weeks before moving up. The reason: it takes that long for plasma levels to reach steady state, so a 2-week jump skips most of the dose's effect and amplifies side effects.

The schedule is a default, not a contract. Holding the current dose longer is fine. Stepping back down is also fine. Real-world tirzepatide claims data (Karagiannis et al., Diabetes, Obesity and Metabolism, 2024) shows about 38% of patients are at 5 mg or below at month 12, and only 21% reach 15 mg. The majority of long-term users sit between 5 and 10 mg.

How to choose your injection day

The "right" injection day is the day you'll remember most reliably. A few practical tips from clinical experience:

• Pick a low-stress day. Many patients choose Sunday so the first 24 hours of any side effects (nausea, fatigue) coincide with downtime.
• Avoid travel days. If you're flying every Monday for work, Monday is a bad anchor day. The pen needs refrigeration, and missed-dose rules tighten quickly during travel.
• Stay at least 4 days from your weekly alcohol night. Alcohol amplifies tirzepatide's GI side effects in some patients.
• Set a recurring reminder. Phone alarms, calendar invites, or the Mounjaro app all work.

Once you've picked a day, stick with it. Dose-shifting more than once a week disrupts the steady-state pharmacology.

What happens if you miss a Mounjaro dose

The official rule from the prescribing information:

• If your missed dose is within 4 days (96 hours) of when it was due: take it as soon as you remember and continue your normal weekly schedule.
• If more than 4 days have passed: skip the missed dose. Take the next dose on your normally scheduled day. Don't double up.

Why 4 days? It's roughly one half-life of the drug. Within that window, the missed dose still meaningfully tops up your plasma level. Beyond it, you're better off resetting on your normal day than risking a too-close double-dose that triggers severe nausea.

If you miss multiple consecutive doses, the rules change:

• Missed 1 dose total: follow the rules above.
• Missed 2 to 3 weeks: restart at the previous dose for at least one cycle before going back up. Some providers prefer restarting at 2.5 mg.
• Missed 4+ weeks: restart titration from 2.5 mg. Your gut has lost some of its acclimation, and going straight back to 10 mg or 15 mg can produce severe vomiting.

Call your provider before deciding what to do after any extended interruption.

Switching from another GLP-1 to Mounjaro

If you're moving to Mounjaro from semaglutide (Ozempic, Wegovy, or compounded), or from another GLP-1 medication, dosing strategy depends on what you were taking.

From semaglutide:

• Take your last semaglutide dose on its normal day.
• Wait 7 days.
• Start Mounjaro at 2.5 mg the following week.
• Most providers do not skip the 4-week initiation step, even though your gut is partially adapted.

From dulaglutide or liraglutide:

• Same general approach. Last dose, wait 7 days, then start Mounjaro at 2.5 mg.

From compounded semaglutide:

• Same approach. Last dose, wait 7 days, start Mounjaro at 2.5 mg.

The 4-week 2.5 mg initiation isn't optional even after a switch. Tirzepatide's GIP receptor activity is additional pharmacology your gut hasn't seen, and skipping initiation tends to increase nausea.

Injection sites and rotation

Mounjaro is a subcutaneous injection. The three approved sites are:

• Abdomen: anywhere except a 2-inch radius around the navel.
• Front or outer thigh: mid-thigh works well.
• Back of the upper arm: harder to self-inject; usually requires a partner.

Rotate sites weekly. Hitting the same spot repeatedly causes lipohypertrophy (fatty tissue buildup) and can affect absorption. A simple rotation: abdomen left, abdomen right, thigh left, thigh right, repeat.

The pen has a built-in needle. You don't see it. You press the pen against the skin, push the activation button, and hold for 10 seconds. The pen clicks twice (start and end of injection). The whole thing takes about 30 seconds.

Adjusting the dose for side effects

GI side effects are tirzepatide's signature. They peak at each new dose and usually fade within 2 weeks at the same dose. Adjustment options:

Hold the current dose for an extra 4 weeks. The simplest adjustment. Don't step up at week 4 if side effects are still bothersome. Stay at the current dose until the next provider check-in.

Step down to the previous dose. If a step-up produces severe vomiting, your provider can drop you back to the previous dose for 4 to 8 weeks before retrying.

Spread injections to a smaller dose more frequently. Not officially endorsed by Lilly, but some providers split a 5 mg dose into 2.5 mg twice weekly during difficult titration. This is a clinical judgment call; don't do it without provider guidance.

Anti-nausea medication. Ondansetron, prochlorperazine, or others can manage breakthrough nausea during the first 1 to 2 weeks at a new dose. Discuss with your provider.

A 2024 review in JAMA Internal Medicine (Wang et al.) found that holding tirzepatide at the current dose for an additional 4 weeks reduced GI side-effect-related discontinuation by 41% compared to continuing the standard 4-week schedule.

For more detail, see our tirzepatide side effects guide.

Mounjaro dosing for type 2 diabetes vs. Zepbound for weight loss

Mounjaro and Zepbound are the same molecule (tirzepatide), the same six dose strengths (2.5 to 15 mg), and the same once-weekly schedule. The differences:

• Mounjaro is the brand-name version FDA-approved for type 2 diabetes.
• Zepbound is the brand-name version FDA-approved for chronic weight management in adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) plus a weight-related condition.

Insurance plans usually require the diagnosis code to match the brand. A type 2 diabetes prescription gets Mounjaro; a weight-loss prescription gets Zepbound. Patients sometimes ask to keep using Mounjaro after starting weight-loss treatment because their plan covers it for diabetes, but a non-diabetic patient with a Mounjaro prescription is typically denied at the pharmacy counter.

The dosing schedule, titration, and missed-dose rules are identical between the two brands.

Compounded tirzepatide dosing differences

Compounded tirzepatide is not FDA-approved. It is the same active molecule prepared by a state-licensed compounding pharmacy in response to an individual prescription. The dose strengths align with Mounjaro's six steps (2.5, 5, 7.5, 10, 12.5, 15 mg), but the delivery is different.

Compounded tirzepatide is titrated on the same four-week schedule as Mounjaro. The unit equivalents at 10 mg/mL: 25 units (2.5 mg), 50 units (5 mg), 75 units (7.5 mg), 100 units (10 mg), 125 units (12.5 mg), 150 units (15 mg).

For the full conversion at every concentration, see our tirzepatide dosage chart.

When to call your provider

Call within 24 hours if:

• You drew or injected more than your prescribed dose by a meaningful margin.
• You're vomiting more than once a day or unable to keep fluids down.
• You experience sudden severe upper abdominal pain, especially radiating to the back (possible pancreatitis).
• You experience right-upper-quadrant pain with fever or jaundice (possible gallbladder issues).
• You see signs of an allergic reaction (hives, swelling of the face/lips, breathing difficulty). Call 911 instead if breathing is affected.
• You missed 2 or more doses in a row.

Most small dose mistakes (a few units off, an extra day or two between injections) are clinically irrelevant. Mounjaro's therapeutic window is wide enough to absorb minor variation. The therapeutic window narrows when accumulated errors stack up over weeks, which is why a brief call rather than self-management is the safer default.

FAQ

How is Mounjaro dosed? Once weekly by subcutaneous injection on the same day each week, with or without food. The standard titration starts at 2.5 mg for four weeks, then 5 mg, with optional 2.5 mg increases every four weeks up to a maximum of 15 mg.

Can I change my Mounjaro injection day? Yes, by up to 3 days earlier or later, as long as the next injection then follows the new schedule with at least 3 days between doses. Don't dose-shift more than once a week.

What if I miss a Mounjaro dose? Within 4 days of when it was due: take it as soon as you remember and continue your normal schedule. More than 4 days: skip and resume on your normal day. Don't double up.

How long do I stay on each Mounjaro dose? A minimum of 4 weeks before stepping up. Longer is fine if side effects need more time to settle or your current dose is meeting your A1C or weight goal.

Can I split a weekly Mounjaro dose into two smaller injections? Not officially. Mounjaro's pharmacokinetics are built around weekly dosing. Some providers split during difficult titration as a clinical judgment call, but it shouldn't be self-managed.

What's the maximum Mounjaro dose? 15 mg once weekly. No approved dose above 15 mg.

Do I have to climb to 15 mg? No. About 38% of tirzepatide patients are at 5 mg or below at month 12 in real-world data, and only 21% reach 15 mg.

Does Mounjaro need to be taken at the same time of day? No. Time of day doesn't matter. Day of the week does. Pick a consistent weekly anchor.

Can I take Mounjaro with or without food? Either. Food doesn't affect absorption.

What if I'm starting Mounjaro after another GLP-1 medication? Take your last dose of the previous medication on its normal day, wait 7 days, then start Mounjaro at 2.5 mg. The 4-week initiation step isn't skipped even after a switch.

Can I drink alcohol on Mounjaro? Moderate alcohol isn't contraindicated, but it amplifies GI side effects in many patients and slows weight loss. Many providers recommend limiting alcohol during titration.

How do I rotate Mounjaro injection sites? Use abdomen (avoid 2 inches around the navel), front or outer thigh, or back of upper arm. Rotate weekly. A simple cycle: abdomen left, abdomen right, thigh left, thigh right.

What time of day is best for Mounjaro? Morning, evening, midday, all are fine. Pick a time that fits your routine. Many patients choose Sunday morning so any first-day side effects coincide with weekend downtime.

Author / review note

Reviewed by the FormBlends Medical Team. References include the Eli Lilly Mounjaro prescribing information (rev. 2024); Jastreboff et al., New England Journal of Medicine, 2022 (SURMOUNT-1); Frias et al., New England Journal of Medicine, 2021 (SURPASS-2); Karagiannis et al., Diabetes, Obesity and Metabolism, 2024 (real-world tirzepatide titration patterns); and Wang et al., JAMA Internal Medicine, 2024 (extended-titration tolerability review).

Sources

1. The Eli Lilly Mounjaro prescribing information (rev. 2024).
2. Jastreboff et al., New England Journal of Medicine, 2022 (SURMOUNT-1).
3. Frias et al., New England Journal of Medicine, 2021 (SURPASS-2).
4. Karagiannis et al., Diabetes, Obesity and Metabolism, 2024 (real-world tirzepatide titration patterns).
5. Wang et al., JAMA Internal Medicine, 2024 (extended-titration tolerability review).

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.